Habib R, Lévy M, Gubler M C
Paediatrician. 1979;8(5-6):325-48.
The wide utilization of renal biopsy and the introduction of electron microscopic and immunohistologic methods has allowed better definition of the clinico-pathological conditions associated with the nephrotic syndrome (NS). Two major categories of facts can be differentiated. In the first one, diffuse lesions of glomeruli, either secondary to specific diseases, or apparently primary diseases such as membranous or membrano-proliferative glomerulonephropathy (GN) are responsible for the increased permeability of the glomerular capillaries. In most of these, there is evidence that immunological mechanisms play a role in the injury of the glomerular capillary. Any of the following clinical symptoms are suggestive of this category of NS: an acute nephritic onset, a moderate NS, macroscopic hematuria, marked hypertension and/or renal insufficiency, poorly selective proteinuria and decreased plasma C3 levels. Patients affected with any of these glomerulopathies usually do not respond to steroids. In the second one, usually referred to as the idiopathic nephrotic syndrome (INS) the mechanism of glomerular capillary alteration is unknown and the nephrotic syndrome is more marked. Minimal change NS (MCNS) accounts for the great majority of INS and is characterized in most cases by a selective proteinuria, the absence of hematuria, a good response to steroids and a good prognosis. However, in some instances, renal biopsy reveals either diffuse mesangial proliferation (DMP) or focal glomerular sclerosis (which may be superimposed on MCNS or on DMP). In both instances, hematuria may be present and 50--75% of patients do not respond to steroids and have a poor prognosis. There is still considerable controversy about the exact relationship between these 3 patterns. We believe that they are not distinct entities but represent variants of the same disease. In addition to these 2 major categories of NS, there are, in infancy, 2 conditions associated with a NS of poor prognosis: congenital NS of Finnish type and infantile mesangial sclerosis. Since steroid-sensitive nephrosis is by far the commonest cause of NS especially in young children up to 8 years, a renal biopsy should be performed only in 2 instances: (a) when the clinical symptoms suggest diffuse glomerular lesions, and (b) when steroid resistance has been demonstrated.
肾活检的广泛应用以及电子显微镜和免疫组织学方法的引入,使得与肾病综合征(NS)相关的临床病理状况得到了更好的界定。可以区分出两大类情况。第一类,肾小球的弥漫性病变,要么继发于特定疾病,要么是诸如膜性或膜增生性肾小球肾炎(GN)等明显的原发性疾病,这些病变导致肾小球毛细血管通透性增加。在大多数此类情况中,有证据表明免疫机制在肾小球毛细血管损伤中起作用。以下任何一种临床症状都提示此类NS:急性肾炎起病、中度NS、肉眼血尿、显著高血压和/或肾功能不全、选择性差的蛋白尿以及血浆C3水平降低。患有这些肾小球疾病中的任何一种的患者通常对类固醇无反应。第二类,通常称为特发性肾病综合征(INS),肾小球毛细血管改变的机制尚不清楚,肾病综合征更为明显。微小病变NS(MCNS)占INS的绝大多数,在大多数情况下其特征为选择性蛋白尿、无血尿、对类固醇反应良好且预后良好。然而,在某些情况下,肾活检显示为弥漫性系膜增生(DMP)或局灶性肾小球硬化(可能叠加在MCNS或DMP上)。在这两种情况下,可能会出现血尿,50%至75%的患者对类固醇无反应且预后不良。关于这三种模式的确切关系仍存在相当大的争议。我们认为它们不是不同的实体,而是同一疾病的变体。除了这两大类NS外,在婴儿期还有两种与预后不良的NS相关的情况:芬兰型先天性NS和婴儿系膜硬化。由于类固醇敏感性肾病是NS最常见的原因,尤其是在8岁以下的幼儿中,因此仅在以下两种情况下应进行肾活检:(a)临床症状提示弥漫性肾小球病变时;(b)已证明存在类固醇抵抗时。